Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
6
×
san francisco blog main
startups
6
×
boston blog main
boston top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
bristol-myers squibb
cancer
crispr therapeutics
epigenetics
investing
mahesh karande
What
biotech
6
×
drug
new
roundup
annual
attention
cancer
control
medicines
research
startup
therapeutics
today
according
ahead
aiming
aims
akcea
alzheimer’s
ambien
ambys
american
approach
asco
assessed
athena
attendees
based
big
bio
called
camp’s
cases
cash
centers
ceo
chicago
chief
cigarettes
city
Language
unset
Current search:
biotech
×
startups
×
" national top stories "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More